share_log

HC Wainwright & Co. Reiterates Buy on Omega Therapeutics, Maintains $12 Price Target

Benzinga ·  Apr 30 18:20

HC Wainwright & Co. analyst Robert Burns reiterates Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $12 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment